Fournier gangrene: new safety concern of SGLT2 inhibitors

被引:0
|
作者
机构
关键词
D O I
10.1007/s40278-019-61900-8
中图分类号
学科分类号
摘要
引用
收藏
页码:8 / 8
相关论文
共 50 条
  • [21] SGLT2 inhibitors: a narrative review of efficacy and safety
    Nelinson, Donald S.
    Sosa, Jose M.
    Chilton, Robert J.
    JOURNAL OF OSTEOPATHIC MEDICINE, 2021, 121 (02): : 229 - 239
  • [22] Safety of SGLT2 Inhibitors in Patients with Diabetes Mellitus
    Singh, Mahakpreet
    Sharma, Ruchika
    Kumar, Anoop
    CURRENT DRUG SAFETY, 2019, 14 (02) : 87 - 93
  • [23] SGLT2 inhibitors
    Steyn, Lynda
    SA PHARMACEUTICAL JOURNAL, 2018, 85 (01) : 72 - 75
  • [24] SGLT2 inhibitors - A new silver bullet
    Kanakakis, I.
    HELLENIC JOURNAL OF CARDIOLOGY, 2021, 62 (01) : 99 - 100
  • [25] Does lower limb amputation concern all SGLT2 inhibitors?
    Scheen, Andre J.
    NATURE REVIEWS ENDOCRINOLOGY, 2018, 14 (06) : 326 - 328
  • [26] Does lower limb amputation concern all SGLT2 inhibitors?
    André J. Scheen
    Nature Reviews Endocrinology, 2018, 14 : 326 - 328
  • [27] Are SGLT2 Inhibitors New Hypertension Drugs?
    Kario, Kazuomi
    Ferdinand, Keith C.
    Vongpatanasin, Wanpen
    CIRCULATION, 2021, 143 (18) : 1750 - 1753
  • [28] Discovery of a new class of SGLT2 inhibitors
    Mascitti, Vincent
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2010, 240
  • [29] Fournier's Gangrene and Diabetic Ketoacidosis Associated with Sodium Glucose Co-Transporter 2 (SGLT2) Inhibitors: Life-Threatening Complications
    Kasbawala, Kinjal
    Stamatiades, George A.
    Majumdar, Sachin K.
    AMERICAN JOURNAL OF CASE REPORTS, 2020, 21 : 1 - 4